γ-GCSc Inhibitors
The chemical class known as γ-GCSc inhibitors encompasses a wide range of compounds with diverse mechanisms of action that exert an influence on the activity of γ-GCSc. While direct inhibitors are not explicitly listed in this context, the indirect inhibitors presented showcase various mechanisms through which γ-GCSc can be modulated, offering a nuanced understanding of the regulatory processes involved. Methotrexate, a prominent member of the antifolate class, operates by disrupting the folate pathway. By inhibiting dihydrofolate reductase, an enzyme critical for folate metabolism, methotrexate interferes with nucleotide synthesis, impeding cellular processes that depend on folate-derived molecules. This disruption has far-reaching consequences, affecting crucial cellular functions such as DNA synthesis and repair. The indirect modulation of γ-GCSc by methotrexate suggests a complex interplay between metabolic pathways and protein regulation, hinting at the intricate nature of cellular signaling networks.
Phlorizin, another compound with indirect modulatory effects on γ-GCSc, operates through a different mechanism. As a competitive inhibitor of sodium-glucose cotransporters, phlorizin disrupts glucose homeostasis by preventing glucose reabsorption in the kidneys. This alteration in glucose levels can impact glycosylation processes, indirectly influencing the activity of γ-GCSc. The intricate connection between glucose metabolism and protein modification underscores the interconnectedness of various cellular pathways and their potential implications for the regulation of target proteins. Sorafenib, classified as a multikinase inhibitor, showcases yet another avenue of indirect modulation of γ-GCSc. By targeting multiple kinases, including those involved in the MAPK/ERK pathway, sorafenib exerts a broad impact on cellular signaling cascades. The indirect influence on γ-GCSc through the modulation of the MAPK/ERK pathway suggests a cross-talk between different signaling pathways within the cell. Understanding these intricate connections provides valuable insights into potential points of intervention for regulating γ-GCSc activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate indirectly inhibits γ-GCSc by interfering with the folate pathway. As an antifolate agent, it inhibits dihydrofolate reductase, disrupting nucleotide synthesis and affecting γ-GCSc indirectly by modulating cellular processes dependent on folate-derived molecules. | ||||||
Phloridzin dihydrate | 7061-54-3 | sc-215708 sc-215708A | 250 mg 1 g | $49.00 $119.00 | ||
Phlorizin indirectly inhibits γ-GCSc by modulating glucose homeostasis. As an SGLT inhibitor, it reduces glucose uptake in the kidney, impacting glucose availability for glycosylation processes. This indirect modulation of glycosylation pathways can influence γ-GCSc function and related cellular processes. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib indirectly inhibits γ-GCSc through its impact on the MAPK/ERK pathway. As a multikinase inhibitor, it targets RAF kinase, affecting downstream signaling. This modulation can influence γ-GCSc indirectly by altering the cellular signaling milieu associated with MAPK/ERK activation. | ||||||
6-Azauridine | 54-25-1 | sc-221082B sc-221082 sc-221082C sc-221082A | 500 mg 1 g 2 g 5 g | $97.00 $159.00 $295.00 $679.00 | ||
6-Azauridine indirectly inhibits γ-GCSc by interfering with nucleotide metabolism. As a pyrimidine analog, it disrupts RNA synthesis, indirectly impacting γ-GCSc by altering the availability of nucleotide-derived molecules essential for various cellular processes, including glycosylation. | ||||||
Acivicin | 42228-92-2 | sc-200498B sc-200498C sc-200498 sc-200498D | 1 mg 5 mg 10 mg 25 mg | $104.00 $416.00 $655.00 $1301.00 | 10 | |
Acivicin indirectly inhibits γ-GCSc by disrupting glutamine metabolism. As a glutamine analog, it inhibits γ-glutamyltransferase, impacting the γ-glutamyl cycle and influencing γ-GCSc indirectly by modulating cellular processes dependent on glutamine-derived molecules. | ||||||
Sodium oxamate | 565-73-1 | sc-215880 sc-215880B sc-215880C sc-215880D sc-215880A | 5 g 100 g 250 g 1 kg 25 g | $77.00 $469.00 $1106.00 $4111.00 $152.00 | 14 | |
Oxamate indirectly inhibits γ-GCSc by interfering with glycolysis. As a lactate dehydrogenase inhibitor, it disrupts the conversion of pyruvate to lactate, impacting the availability of glycolytic intermediates. This indirect modulation of glycolysis can influence γ-GCSc function and cellular processes. | ||||||
STF 31 | 724741-75-7 | sc-364692 | 10 mg | $187.00 | 3 | |
STF-31 indirectly inhibits γ-GCSc through its impact on the mTOR pathway. As a selective GLUT1 inhibitor, it influences glucose uptake and glycosylation processes, indirectly affecting γ-GCSc by altering cellular signaling cascades associated with mTOR pathway activation. | ||||||
Avasimibe | 166518-60-1 | sc-364315 sc-364315A sc-364315B sc-364315C | 10 mg 50 mg 500 mg 1 g | $109.00 $421.00 $2081.00 $3121.00 | 1 | |
Avasimibe indirectly inhibits γ-GCSc by modulating cholesterol esterification. As an ACAT inhibitor, it impacts lipid metabolism, indirectly influencing γ-GCSc by altering the availability of lipid-derived molecules essential for glycosylation and other cellular processes. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
2-Deoxy-D-Glucose indirectly inhibits γ-GCSc by interfering with glycolysis. As a glucose analog, it disrupts glucose metabolism, impacting glycosylation processes and influencing γ-GCSc indirectly by altering the availability of glycolytic intermediates. | ||||||
6-Diazo-5-oxo-L-norleucine | 157-03-9 | sc-227078 sc-227078A sc-227078B sc-227078C | 5 mg 25 mg 100 mg 250 mg | $88.00 $291.00 $926.00 $2195.00 | ||
DON indirectly inhibits γ-GCSc by disrupting amino acid metabolism. As a glutamine analog, it inhibits multiple aminoacyl-tRNA synthetases, impacting protein synthesis and influencing γ-GCSc indirectly by modulating cellular processes dependent on amino acid-derived molecules. | ||||||